Myasthenia Gravis Clinical Trial
Official title:
The Effect of Spinal Stabilization Exercises on Fatigue, Muscle Strength, Pulmonary Functions and Functional Capacity in Patients With Myasthenia Gravis
Myasthenia Gravis (MG) is an autoimmune disease characterized by increased exercise-induced
fatigue and muscle weakness. MG is a disease caused by impaired receptor function due to
antibodies to nicotinic acetylcholine receptors in postsynaptic region in voluntary skeletal
muscles.Spinal stabilization exercises, which use the basic principles of motor learning,
aiming to improve the coordination, contraction rate and endurance of the body muscles by
increasing kinesthetic awareness, can be used to strengthen body stability.
The aim of this study was to investigate the effects of spinal stabilization exercises on
fatigue, muscle strength, pulmonary functions and functional capacity in patients with MG.
Myasthenia Gravis (MG) is an autoimmune disease characterized by increased exercise-induced
fatigue and muscle weakness. MG is a disease caused by impaired receptor function due to
antibodies to nicotinic acetylcholine receptors in postsynaptic region in voluntary skeletal
muscles. The disease usually begins with ptosis from ocular symptoms. With the progression of
the disease, symptoms of bulbar muscles and extremity muscles are added to the ocular
symptoms. Bulbar symptoms occur when speaking, swallowing, chewing difficulties and
difficulty breathing, while the symptoms in the extremity muscles arise as the difficulty of
raising the arms uphill and the strain of climbing stairs.
The weakness of the limb muscles is proximal and distal in the arms and more proximal muscles
in the legs. As the disease progresses, weakness occurs in most striated muscles. This causes
weakness in the trunk muscles.
In the literature, the physiotherapy methods used in MG patients include breathing exercises,
aerobic exercises and resistant exercises.Spinal stabilization exercises enable activation of
the trunk muscles.
Spinal stabilization exercises, which use the basic principles of motor learning, aiming to
improve the coordination, contraction rate and endurance of the body muscles by increasing
kinesthetic awareness, can be used to strengthen body stability. Spinal stabilization
exercises are a type of exercise that aims more smooth limb movements with a strong spine,
ensuring smoothness and stability of the spine. In the literature, there is no study using
spinal stabilization exercises in MG patients. The aim of this study was to investigate the
effects of spinal stabilization exercises on fatigue, muscle strength, pulmonary functions
and functional capacity in patients with MG.
Method The study was planned as randomized, single-blind and cross-over. Randomization will
be done with closed envelope system. Group 1 will be written on five sheets and group 2 will
be written on another five sheets.
Then, these papers will be placed on the envelopes, these envelopes will be mixed in a box
and patients will be asked to withdraw from these envelopes.
Thus, patients will be divided into 2 groups. Assessments will be made by Yeliz Salcı and
Ebru Kütük Çalıkçı. The assessors will not know who is in the which group. Treatment
intervention will be done by Ali Naim Ceren. The assessors will evaluate patients without
knowing the patients' groups. So the work will be single blind. Group 1, 3 days per week for
6 weeks so that it will be taken to the physiotherapy program consisting of spinal
stabilization exercises. Also the treatment will be supported by home program exercises. The
patients will be rested for 4 weeks to eliminate the effects of the spinal stabilization
program. After this period, only the home program will be given for 6 weeks. In Group 2;
treatment will start with a 6-week home program, followed by a 4-week break.
At the end of this period to be 3 days a week for 6 weeks spinal stabilization exercise
program will be implemented. In addition to this exercise program, patients will be given a
home program. The home program will include breathing exercises tailored to the patient's
needs, calisthenic exercises, and MAT activities.
Assessments will be made at the beginning of the treatment, after 6 weeks of treatment, at
the end of 4 weeks of rest and at the end of 6 weeks of treatment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05039190 -
Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients
|
Phase 3 | |
Recruiting |
NCT04561557 -
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
|
Early Phase 1 | |
Completed |
NCT01727193 -
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
|
Phase 3 | |
Completed |
NCT00285350 -
Mycophenolate Mofetil in Myasthenia Gravis
|
Phase 3 | |
Recruiting |
NCT05890833 -
The Risk of Falls Index for Patients With Neuromuscular Disorders
|
||
Completed |
NCT05694234 -
Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study
|
||
Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
Not yet recruiting |
NCT05095103 -
Immune Profiles in Myasthenia Gravis
|
||
Not yet recruiting |
NCT04965987 -
Oxaloacetate in Myasthenia Gravis
|
Phase 1 | |
Completed |
NCT02774239 -
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
|
Phase 3 | |
Completed |
NCT02066519 -
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
|
N/A | |
Terminated |
NCT02102594 -
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
|
Phase 2 | |
Completed |
NCT02118805 -
Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
|
||
Terminated |
NCT01828294 -
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
|
Phase 1 | |
Terminated |
NCT00727194 -
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
|
Phase 2 | |
Completed |
NCT04590716 -
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
|
||
Recruiting |
NCT04837625 -
Study of Myasthenic Crisis in China
|
||
Not yet recruiting |
NCT01469858 -
Perception and Multisensory Integration in Neurological Patients Using fMRI
|
N/A | |
Completed |
NCT05408702 -
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
|
||
Completed |
NCT03205306 -
Myasthenia Gravis and Psyche
|